Remote ischemic conditioning improves myocardial parameters and clinical outcomes during primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Oncotarget
Hai LiuYiliang Li

Abstract

We conducted a systematic review and meta-analysis to evaluate the effects of remote ischemic conditioning on myocardial parameters and clinical outcomes in ST segment elevation acute myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention. Ten eligible randomized controlled trials with 1006 STEMI patients were identified. Compared with controls, remote ischemic conditioning reduced the myocardial enzyme levels (standardized mean difference =-0.86; 95% CI: -1.44 to -0.28;P =0.004; I2= 94.5%), and increased the incidence of complete ST-segment resolution [odds ratio (OR) = 1.74; 95% CI: 1.09 to 2.77;P =0.02; I2= 47.9%]. Remote ischemic conditioning patients had a lower risk of all-cause mortality (OR = 0.27; 95% CI: 0.12 to 0.62;P =0.002; I2= 0.0%) and lower major adverse cardiovascular and cerebrovascular events rate (OR=0.45; 95% CI: 0.27 to 0.75;P =0.002; I2= 0.0%). Meta-analysis suggested that remote ischemic conditioning conferred cardioprotection by reducing myocardial enzymes and increasing the incidence of complete ST-segment resolution in patients after STEMI. As a result, clinical outcomes were improved in terms of mortality and incidence of major adverse cardiovascular and cerebrov...Continue Reading

References

Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Nov 3, 2001·Journal of the American College of Cardiology·J A de Lemos, E Braunwald
May 22, 2002·Circulation·Subodh VermaTerrence M Yau
Aug 6, 2002·Cardiovascular Research·Sebastian WolfrumAndreas Dendorfer
Sep 19, 2003·Journal of the American College of Cardiology·Giuseppe De LucaUNKNOWN ZWOLLE Myocardial Infarction Study Group
Sep 15, 2007·The New England Journal of Medicine·Derek M Yellon, Derek J Hausenloy
Dec 15, 2007·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Wanjun LuoGuoqiang Lin
Feb 22, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Mark B NienhuisFelix Zijlstra
May 6, 2008·Cardiovascular Research·Derek J Hausenloy, Derek M Yellon
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
May 8, 2010·Cardiovascular Research·Michel OvizeUNKNOWN Working Group of Cellular Biology of Heart of European Society of Cardiology
Jun 9, 2012·Journal of the American College of Cardiology·Franck ThunyPierre Croisille
Oct 23, 2012·International Journal of Cardiology·Chenghui Zhou, Lihuan Li
Mar 20, 2013·The Journal of Thoracic and Cardiovascular Surgery·Wouter OosterlinckPaul Herijgers
Mar 26, 2013·Basic Research in Cardiology·Hussain ContractorRajesh K Kharbanda
Oct 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Zheqing CaiGregg L Semenza
Mar 20, 2014·Circulation Research·Tienush RassafMalte Kelm
Jan 17, 2015·Journal of the American College of Cardiology·Gerd HeuschDerek Yellon
Jun 27, 2015·Journal of the American College of Cardiology·Derek M YellonDerek J Hausenloy
Jun 25, 2016·Basic Research in Cardiology·Jack M J PickardDerek M Yellon

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.